What question did this study set out to answer?

To compare overall survival (OS) and progression-free survival (PFS) between PD-(L)1 inhibitor monotherapy and chemoimmunotherapy in advanced NSCLC patients.

June 6, 2026JAMA Oncology

PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression

View Full Paper

Ask AI

Bookmark

Authors

AFAlessandro Di FedericoAzienda USL di Bologna SCSamuele CompagnoAzienda USL di Bologna FMFrancesco MantuanoAzienda USL di Bologna

Discussion

Member takes

Implication

Randomized trial compares survival outcomes in advanced NSCLC patients with high PD-L1 expression, indicating chemoimmunotherapy is superior.

Key Points

To compare overall survival (OS) and progression-free survival (PFS) between PD-(L)1 inhibitor monotherapy and chemoimmunotherapy in advanced NSCLC patients.
Included 24 phase 3 randomized clinical trials with 5546 patients.
Compared outcomes of PD-(L)1 inhibitor monotherapy and chemoimmunotherapy versus chemotherapy alone.
Analyzed data for OS and PFS using hazard ratios and additional statistical methods.
Chemoimmunotherapy improved OS compared to PD-(L)1 inhibitor monotherapy (29.2 months vs 19.8 months; HR, 0.74; P < .001).
PFS was longer with chemoimmunotherapy than PD-(L)1 inhibitor monotherapy (11.3 months vs 6.8 months; HR, 0.67; P < .001).
Subgroup analysis confirmed a significant benefit of chemoimmunotherapy over PD-(L)1 inhibitor monotherapy.

Cite This Study

Federico et al. (2026) studied this question.

synapsesocial.com/papers/6a23bbeb71a5da9775e7748a https://doi.org/10.1001/jamaoncol.2026.1548

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial compares survival outcomes in advanced NSCLC patients with high PD-L1 expression, indicating chemoimmunotherapy is superior.

PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression

Discussion

Member takes

Implication

Key Points

Cite This Study

PD-(L)1 Inhibitor Monotherapy vs Chemoimmunotherapy for Advanced NSCLC With High PD-L1 Expression

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider